Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Puma Biotechnology in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Puma Biotechnology.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	1	1	1	1	1	0
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-6.29%	Feb 28, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-6.29%	Dec 23, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-6.29%	Nov 20, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-6.29%	Nov 8, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-6.29%	Aug 2, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

222.36M

Decreased by -2.63%

from 228.37M

Revenue Next Year

222.36M

from 222.36M

EPS This Year

0.41

Decreased by -33.11%

from 0.61

EPS Next Year

0.66

Increased by 62.50%

from 0.41

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	253.16M	228.03M	235.64M	230.47M	228.37M	222.36M	222.36M
Revenue Growth	12.46%	-9.92%	3.34%	-2.19%	-0.91%	-2.63%	-
EPS	-0.72	0.00	0.45	0.62	0.61	0.41	0.66
EPS Growth	-	-	1,022,625.00%	37.78%	-1.61%	-33.11%	62.50%
Forward PE	-	-	-	-	-	18.31	11.27
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	228.9M	228.9M
Avg	222.4M	222.4M
Low	213.6M	213.6M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	0.2%	2.9%
Avg	-2.6%	-
Low	-6.5%	-3.9%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	0.42	0.68
Avg	0.41	0.66
Low	0.39	0.64

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-31.1%	67.3%
Avg	-33.1%	62.5%
Low	-35.7%	56.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.